SAN DIEGO, CA – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its portfolio company HempMeds® is a premiere sponsor of the Aug. 6-7 Southern California Cannabis Conference and Expo (SocalCCExpo), the first-ever professional and educational medical cannabis Expo to be held at the San Diego Convention Center.
In addition, Medical Marijuana, Inc.’s CEO Dr. Stuart Titus will speak at the Expo on Aug. 7 at 1 p.m. on “Cannabis and Medical Research,” giving a history of the medical cannabis industry and an explanation of cannabis medical research over the decades.
“Day-by-day we are working to change the world’s perception of medical marijuana, which is why I am always honored to attend and be invited to speak at events such as this Expo, as they provide tremendous opportunities for us to raise even more awareness of the plethora of medical benefits that come from cannabis,” Titus said. “For instance, attendees will have the opportunity to see for themselves our products, such as RSHO-X™, which is made right here in San Diego and shipped to Mexico as the first-ever federally approved cannabis product there.”
HempMeds® will be offering its best terms on new wholesale partnerships at the Expo. Cannabis retailers or distributors interested in CBD hemp oil can meet with the Head of Sales for HempMeds® at the Expo by visiting the Company’s SocalCCExpo site to schedule a meeting time. HempMeds® also has announced a “We’re Hiring” campaign and has positions open for sales positions in San Diego. Applicants interested in joining the booming cannabis industry can apply on the Company’s Careers Page and are encouraged to visit the HempMeds®Pavilion #509 to meet representatives in person.
Representatives from Medical Marijuana, Inc. and its portfolio companies HempMeds® and Kannaway® will be at the event, and HempMeds®will be exhibiting retail-ready cannabis products at Pavilion #509, including its zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™), the first-ever cannabis product to receive approval from the federal government of Mexico for importation. HempMeds® representatives and Dr. Titus will also be available to discuss how Real Scientific Hemp Oil™ (RSHO™) was approved for import into Brazil and subsidized by the Brazilian government’s federal healthcare system.
The CEO of Medical Marijuana, Inc.’s PR firm CMW Media, Andrew Hard, will also be presenting at the Expo on Aug. 7 at 12 p.m. about “Children and Cannabis, Safety & Health.” Hard will be joined by three-year-old San Diego girl Sadie Higuera and her father Brian Higuera, who will share Sadie’s miraculous story with medical cannabis. Dallas mom and RSHO™ advocate Penny Howard will also speak with her 8-year-old daughter Lilly about how sharing her late daughter Harper’s story to Facebook helped a family in Brazil. Through the Hope4Harper non-profit, Penny raises awareness for CDKL5, directly leading to a series of challenges to marijuana policies in Brazil.
For more information on HempMeds® and their all-natural hemp oil products, visit: www.hempmeds.com. For more information on the SocalCCExpo, visit: https://socalccexpo.com or HempMeds® SocalCCExpo site.
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
P. 888-829- 0070
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500